Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of EVRA transdermal contraceptive patch versus oral drospirenone + ethinylestradiol in Chinese women
CTR20260334Phase 3Active
- Sponsor
- Gedeon Richter Plc
- Start
- Apr 2026
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + norelgestromin, sponsored by Gedeon Richter Plc. Started Apr 2026; status: active.
02
Drugs
ethinyl estradiol + norelgestromin
Beyond the preview
Go deeper on CTR20260334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260334.